CD47 and cancer: Our results reveal that CD47 mRNA or protein levels exhibit notable overexpression across a broad spectrum of TCGA cancers, prominently including BRCA, CHOL, COAD, ESCA, HNSC, KIRC, LIHC, PAAD, STAD, THCA, and UCEC.